The Guideline Development Group convened a meeting on 12-14 November 2019 on update of the World Health Organization (WHO) drug-resistant TB treatment guidelines.
The scope of the upcoming guidelines update is driven by the need to ensure rapid access to better treatment options for people with drug-resistant TB and is expected to be addressed by review of the new data pledged by member states and technical partners of WHO.
The WHO Global TB Program released an announcement detailing the whole preparation process for the meeting. The announcement can be accessed here.
Source: WHO Global TB Program